Literature DB >> 16229995

Carbohydrate mimicry: a new paradigm of autoimmune diseases.

Nobuhiro Yuki1.   

Abstract

Molecular mimicry of microbial components by self components is thought to be the mechanism that accounts for the antigen and tissue specificity of immune responses in post-infectious autoimmune diseases. Little direct evidence exists, and research in this area has focused principally on T cell mediated anti-peptide responses, rather than on humoral responses to carbohydrate structures. Guillain-Barré syndrome, the most frequent cause of acute neuromuscular paralysis, sometimes occurs after Campylobacter jejuni enteritis. Recent studies have revealed that carbohydrate mimicry of the bacterial lipo-oligosaccharide by the human ganglioside is an important cause of the syndrome. This new concept that carbohydrate mimicry can cause an autoimmune disease provides a clue to inducing the resolution of pathogenesis of other immune-mediated diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16229995     DOI: 10.1016/j.coi.2005.09.004

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  25 in total

1.  Pathogenesis and treatment of immune-mediated neuropathies.

Authors:  Helmar C Lehmann; Gerd Meyer Zu Horste; Bernd C Kieseier; Hans-Peter Hartung
Journal:  Ther Adv Neurol Disord       Date:  2009-07       Impact factor: 6.570

2.  O-Acetylation of sialic acid on Group B Streptococcus inhibits neutrophil suppression and virulence.

Authors:  Shannon Weiman; Satoshi Uchiyama; Feng-Ying C Lin; Donald Chaffin; Ajit Varki; Victor Nizet; Amanda L Lewis
Journal:  Biochem J       Date:  2010-05-13       Impact factor: 3.857

Review 3.  Ganglioside molecular mimicry and its pathological roles in Guillain-Barré syndrome and related diseases.

Authors:  Robert K Yu; Seigo Usuki; Toshio Ariga
Journal:  Infect Immun       Date:  2006-09-11       Impact factor: 3.441

4.  Sialic acid-binding immunoglobulin-like lectin 7 mediates selective recognition of sialylated glycans expressed on Campylobacter jejuni lipooligosaccharides.

Authors:  Tony Avril; Eric R Wagner; Hugh J Willison; Paul R Crocker
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 5.  Structural and dynamic views of GM1 ganglioside.

Authors:  Maho Yagi-Utsumi; Koichi Kato
Journal:  Glycoconj J       Date:  2015-05-01       Impact factor: 2.916

Review 6.  Guillain-barré syndrome.

Authors:  Satoshi Kuwabara
Journal:  Curr Neurol Neurosci Rep       Date:  2007-01       Impact factor: 5.081

7.  Genetics behind the Biosynthesis of Nonulosonic Acid-Containing Lipooligosaccharides in Campylobacter coli.

Authors:  Mirko Rossi; Michel Gilbert; Warren Wakarchuk; Alejandra Kolehmainen; Jacek Stupak; Jianjun Li
Journal:  J Bacteriol       Date:  2019-03-26       Impact factor: 3.490

8.  Draft genome sequences of two Campylobacter jejuni clinical isolates, NW and D2600.

Authors:  John P Jerome; Brian D Klahn; Julia A Bell; Jeffrey E Barrick; C Titus Brown; Linda S Mansfield
Journal:  J Bacteriol       Date:  2012-10       Impact factor: 3.490

9.  Assessment of the duration of protection in Campylobacter jejuni experimental infection in humans.

Authors:  David R Tribble; Shahida Baqar; Daniel A Scott; Michael L Oplinger; Fernando Trespalacios; David Rollins; Richard I Walker; John D Clements; Steven Walz; Paul Gibbs; Edward F Burg; Anthony P Moran; Lisa Applebee; A Louis Bourgeois
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

Review 10.  The interplay between Siglecs and sialylated pathogens.

Authors:  Yung-Chi Chang; Victor Nizet
Journal:  Glycobiology       Date:  2014-07-04       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.